Dr Will Maier

Chief Scientific Officer

Back to Speakers

Dr. William Maier, PhD, Mapi’s Chief Scientific Officer, has more than 20 years of drug development and commercialization
experience, and he provides invaluable insight to sponsors.

His promotion of a new pharmacoepidemiology, risk management, and research methodology—and his application of innovative technology to improve efficiency and accuracy of post-marketing surveillance studies—has proven invaluable to rare disease researchers.